Factorial Partners LLC Acquires Shares of 3,000 Humana Inc. $HUM

Factorial Partners LLC acquired a new stake in shares of Humana Inc. (NYSE:HUM) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,000 shares of the insurance provider’s stock, valued at approximately $781,000.

Several other large investors also recently modified their holdings of the business. Massachusetts Financial Services Co. MA raised its position in Humana by 273.2% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,488,261 shares of the insurance provider’s stock valued at $907,541,000 after purchasing an additional 2,553,509 shares during the last quarter. Norges Bank purchased a new position in shares of Humana during the second quarter valued at approximately $397,079,000. Bank of New York Mellon Corp increased its stake in shares of Humana by 161.5% during the third quarter. Bank of New York Mellon Corp now owns 1,717,767 shares of the insurance provider’s stock valued at $446,911,000 after buying an additional 1,060,767 shares during the period. Dodge & Cox raised its holdings in shares of Humana by 5.6% during the second quarter. Dodge & Cox now owns 11,352,920 shares of the insurance provider’s stock valued at $2,775,562,000 after acquiring an additional 597,705 shares in the last quarter. Finally, 8 Knots Management LLC lifted its stake in Humana by 671.0% in the second quarter. 8 Knots Management LLC now owns 441,623 shares of the insurance provider’s stock worth $107,968,000 after acquiring an additional 384,345 shares during the period. 92.38% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on HUM. Barclays reissued an “underperformer” rating on shares of Humana in a research report on Monday, January 5th. Jefferies Financial Group reduced their price target on shares of Humana from $310.00 to $235.00 and set a “buy” rating on the stock in a research report on Thursday, February 12th. The Goldman Sachs Group lowered their price objective on shares of Humana from $215.00 to $158.00 and set a “sell” rating for the company in a report on Friday, February 13th. Oppenheimer set a $250.00 price objective on Humana in a research report on Thursday, February 12th. Finally, Morgan Stanley set a $146.00 target price on Humana in a research report on Thursday, February 12th. Seven equities research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and four have given a Sell rating to the stock. According to MarketBeat, Humana has an average rating of “Hold” and an average target price of $228.48.

Humana Trading Down 0.3%

NYSE:HUM opened at $189.95 on Friday. The firm has a market capitalization of $22.85 billion, a P/E ratio of 19.34, a PEG ratio of 2.03 and a beta of 0.44. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.00 and a quick ratio of 2.02. Humana Inc. has a one year low of $169.61 and a one year high of $315.35. The company’s 50-day simple moving average is $237.44 and its 200 day simple moving average is $258.76.

Humana (NYSE:HUM) last released its earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share (EPS) for the quarter, beating the consensus estimate of ($4.01) by $0.05. Humana had a net margin of 0.92% and a return on equity of 11.43%. The firm had revenue of $32.64 billion during the quarter, compared to analyst estimates of $32.08 billion. During the same period last year, the business earned ($2.16) earnings per share. The business’s revenue was up 11.3% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. As a group, analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date of this dividend is Friday, March 27th. Humana’s dividend payout ratio is currently 36.05%.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.